SAREPTA THERAPEUTICS, INC. Inventory, Work in Process and Raw Materials, Net of Reserves
SAREPTA THERAPEUTICS, INC. (SRPT) had Inventory, Work in Process and Raw Materials, Net of Reserves of $258.26 million as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes
us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves · last filed 2023-11-01
- 2023-09-30: Inventory, Work in Process and Raw Materials, Net of Reserves $258.26M.
- 2023-06-30: Inventory, Work in Process and Raw Materials, Net of Reserves $243.06M.
- 2023-03-31: Inventory, Work in Process and Raw Materials, Net of Reserves $239.66M.
- 2022-12-31: Inventory, Work in Process and Raw Materials, Net of Reserves $269.19M.
| Period end | Inventory, Work in Process and Raw Materials, Net of Reserves |
|---|---|
| 2023-09-30 | $258.26M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $243.06M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $239.66M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $269.19M 10-Q · filed 2023-11-01 |
| 2022-09-30 | $250.39M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $253.20M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $245.27M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $230.19M 10-K · filed 2023-02-28 |
| 2021-09-30 | $221.48M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $191.51M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $149.81M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $139.70M 10-K · filed 2022-03-01 |
| 2020-09-30 | $135.43M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $100.05M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $84.52M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $88.03M 10-K · filed 2021-03-01 |
| 2019-09-30 | $90.49M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $78.35M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $66.88M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $47.28M 10-K · filed 2020-02-26 |
| 2018-09-30 | $42.54M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $37.11M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $34.61M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $27.44M 10-K · filed 2019-02-28 |
| 2017-09-30 | $20.14M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $13.78M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $5.43M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.17M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |